Cellular immunology of relapsing multiple sclerosis: interactions, checks, and balances

A Bar-Or, R Li - The Lancet Neurology, 2021 - thelancet.com
Novel insights from basic and translational studies are reshaping concepts of the
immunopathogenesis of multiple sclerosis and understanding of the different inflammatory …

The CXCL13/CXCR5 immune axis in health and disease—Implications for intrathecal B cell activities in neuroinflammation

C Harrer, F Otto, RF Radlberger, T Moser, G Pilz… - Cells, 2022 - mdpi.com
The chemokine CXC-ligand 13 (CXCL13) is a major B cell chemoattractant to B cell follicles
in secondary lymphoid organs (SLO) that proposedly recruits B cells to the cerebrospinal …

Early B cell tolerance defects in neuromyelitis optica favour anti-AQP4 autoantibody production

E Cotzomi, P Stathopoulos, CS Lee, AM Ritchie… - Brain, 2019 - academic.oup.com
Neuromyelitis optica spectrum disorders (NMOSD) constitute rare autoimmune disorders of
the CNS that are primarily characterized by severe inflammation of the spinal cord and optic …

Recent progress in multiple sclerosis treatment using immune cells as targets

X Ma, R Ma, M Zhang, B Qian, B Wang, W Yang - Pharmaceutics, 2023 - mdpi.com
Multiple sclerosis (MS) is an autoimmune-mediated demyelinating disease of the central
nervous system. The main pathological features are inflammatory reaction, demyelination …

Astrocyte-specific expression of interleukin 23 leads to an aggravated phenotype and enhanced inflammatory response with B cell accumulation in the EAE model

L Nitsch, S Petzinna, J Zimmermann… - Journal of …, 2021 - Springer
Background Interleukin 23 is a critical cytokine in the pathogenesis of multiple sclerosis. But
the local impact of interleukin 23 on the course of neuroinflammation is still not well defined …

Oxidative phosphorylation regulates B cell effector cytokines and promotes inflammation in multiple sclerosis

R Li, Y Lei, A Rezk, DA Espinoza, J Wang, H Feng… - Science …, 2024 - science.org
Dysregulated B cell cytokine production contributes to pathogenesis of immune-mediated
diseases including multiple sclerosis (MS); however, the underlying mechanisms are poorly …

The role of B cells in multiple sclerosis: Current and future therapies

A Negron, RR Robinson, O Stüve, TG Forsthuber - Cellular immunology, 2019 - Elsevier
While it was long held that T cells were the primary mediators of multiple sclerosis (MS)
pathogenesis, the beneficial effects observed in response to treatment with Rituximab (RTX) …

[HTML][HTML] Longitudinally persistent cerebrospinal fluid B cells can resist treatment in multiple sclerosis

AL Greenfield, R Dandekar, A Ramesh, EL Eggers… - JCI insight, 2019 - ncbi.nlm.nih.gov
B cells are key contributors to chronic autoimmune pathology in multiple sclerosis (MS).
Clonally related B cells exist in the cerebrospinal fluid (CSF), meninges, and CNS …

Spontaneous human CD8 T cell and autoimmune encephalomyelitis-induced CD4/CD8 T cell lesions in the brain and spinal cord of HLA-DRB1* 15-positive multiple …

I Papazian, M Kourouvani, A Dagkonaki, V Gouzouasis… - eLife, 2024 - elifesciences.org
Autoimmune diseases of the central nervous system (CNS) such as multiple sclerosis (MS)
are only partially represented in current experimental models and the development of …

Decoding intrathecal immunoglobulins and B cells in the CNS: their synthesis, function, and regulation: Modulation of immune responses mediated by different B cells …

N Negi, BK Das - International Reviews of Immunology, 2020 - Taylor & Francis
The discovery of an active lymphatic system in the meninges (dura mater) has opened up a
wide range of possibilities for the role of CNS immunoglobulins in brain development in …